Medical Design Technology

The Essential Resource for the Medical Design Engineering Community

Subscribe to MDT Magazine All

Reports Fourth Quarter and Full Year 2012 Financial Results

February 19, 2013 4:05 pm | by The Associated Press | News | Comments

NASHUA, N.H.--(BUSINESS WIRE)--Feb 19, 2013--(Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31,...

Solta Medical Reports Fourth Quarter and Full Year 2012 Results

February 19, 2013 4:03 pm | by The Associated Press | News | Comments

Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced results for the fourth quarter ended December 31, 2012. Revenue for the fourth quarter was $39.8 million, an increase of $6.6 million, or 20%, as compared to the fourth quarter of 2011. ...

Sen. Elizabeth Warren Will Seek Industry's Help on Medical Device Tax Repeal

February 19, 2013 3:47 pm | by Mass Device | News | Comments

Newly elected Sen. Elizabeth Warren (D-Mass.) is looking to talk with medical device makers about ongoing efforts to repeal the medical device tax, although she has yet to sign her name to a new Senate bill to do just that, she told MassDevice.com today.

TOPICS:
Advertisement

Connector Line Expanded with Additional Material Options

February 19, 2013 3:20 pm | by MDT Staff | Colder Products Company | Product Releases | Comments

Colder Products Company, the leading provider of quick disconnect couplings and fittings for plastic tubing, announces the addition of PVDF to the available material options throughout its FitQuik® Connectors product line.

Antimicrobial Compounds Help Designers Enhance Safety of Healthcare Applications

February 19, 2013 3:13 pm | by MDT Staff | Sabic Innovative Plastics | Product Releases | Comments

SABIC’s Innovative Plastics business today introduced powerful new tools to help medical device manufacturers reduce HCAIs among patients and clinicians. SABIC’s nine new antimicrobial compounds featuring silver technology have been tested for log reduction values – the level of microbes eliminated from a surface – according to the ISO 22196-2007 protocol.

Cardiovascular Systems Sponsoring Orbital Atherectomy Sessions at iCON 2013

February 19, 2013 3:00 pm | by The Associated Press | News | Comments

ST. PAUL, Minn. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Feb 19, 2013--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), announced today it is sponsoring a challenging case presentation featuring its peripheral orbital atherectomy system, and co-hosting an office-based lab presentation and...

TOPICS:

Successful Med-Tech Veteran Joins Board of Tenex Health

February 19, 2013 3:00 pm | by The Associated Press | News | Comments

LAKE FOREST, Calif.--(BUSINESS WIRE)--Feb 19, 2013--Tenex Health, a pioneer in image-guided soft tissue repair, is pleased to announce the appointment of Doug Kohrs to the company's board of directors. Doug brings more than 30 years of experience in medical devices with 20 of those years spent as...

OraQuick In-Home HIV Test Named a "Top Health Breakthrough of 2012" by Men's Health Magazine

February 19, 2013 2:58 pm | by Globe Newswire | News | Comments

OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that the Company's OraQuick(R) In-Home HIV Test, the first ever in-home rapid infectious disease test made available directly to consumers, has been named a "Top Health Breakthrough of 2012" by Men's Health magazine.

TOPICS:
Advertisement

BioDtech, Inc. Issued New United States Patent

February 19, 2013 2:42 pm | by The Associated Press | News | Comments

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Feb 19, 2013--BioDtech, Inc., a biotechnology company engaged in the development of cutting-edge products for the endotoxin market, announced that it has been granted a patent, by the United States patent office (No. 8,349,570), protecting methods of endotoxin...

Kimberly-Clark Introduces Revolutionary Cervicool Cooled Radiofrequency System for Cervical Joint Pain

February 19, 2013 2:32 pm | by Kimberly-Clark | News | Comments

Kimberly-Clark has announced the launch of CERVICOOL Cooled Radiofrequency (RF) System, an innovative option for helping resolve cervical facet joint pain. With the addition of CERVICOOL Cooled RF System, Kimberly-Clark now offers a complete portfolio of cooled radiofrequency treatment for all segments of the spine, from the cervical facet joint to the sacroiliac joint.

TOPICS:

Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System

February 19, 2013 2:22 pm | by Medtronic | News | Comments

Showcasing its leadership position in pacing technologies, Medtronic, Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of its Advisa DR MRI SureScan pacing system. The Advisa MRI system is Medtronic’s second-generation MR-Conditional pacemaker and is the first system to combine the most advanced pacing technology with proven MRI access.

TOPICS:

Bonesupport Lands CE Mark for Next-Gen Antibiotic Bone Graft Substitute

February 19, 2013 2:18 pm | by Mass Device | News | Comments

Swedish orthopedic trauma products maker Bonesupport won CE Mark approval in the European Union for its next-generation Cerament|G injectable antibiotic-eluting bone substitute. The Cerament|G product is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis.

TOPICS:

Jonathan S. Helfgott, FDA Compliance Officer for Center for Drug Evaluation & Research (CDER), to Address PHT Corporation U.S. PRO & eCOA Congress

February 19, 2013 1:55 pm | by The Associated Press | News | Comments

BOSTON & GENEVA--(BUSINESS WIRE)--Feb 19, 2013--PHT Corporation announced that Jonathan S. Helfgott, FDA Compliance Officer for CDER, within the office of Scientific Investigations, will present: “FDA Perspective on the Compliant Use of ePRO Instruments to Support FDA Studies” at the 17 thPRO...

TOPICS:

New Drug Combination Could Prevent Head and Neck Cancer in High-risk Patients

February 19, 2013 1:00 pm | by AACR | News | Comments

A new drug combination shows promise in reducing the risk for patients with advanced oral precancerous lesions to develop squamous cell carcinoma of the head and neck. The results of the study, which included preclinical and clinical analyses, were published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

TOPICS:

Geomagic Showcases Touch-Enabled Virtual Reality Solutions at NextMed/MMVR20 Conference

February 19, 2013 12:29 pm | by The Associated Press | News | Comments

MORRISVILLE, N.C.--(BUSINESS WIRE)--Feb 19, 2013--Geomagic®, a global company providing 3D technology for digital reality, has announced that it will showcase innovative touch-enabled medical simulation and training applications developed by its OEM partners and educational customers.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading